3373 Stock Overview
Radiant Innovation Inc. designs and develops infrared technology products.
Radiant Innovation Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$27.20|
|52 Week High||NT$42.50|
|52 Week Low||NT$18.50|
|1 Month Change||26.22%|
|3 Month Change||17.75%|
|1 Year Change||-32.25%|
|3 Year Change||58.60%|
|5 Year Change||58.60%|
|Change since IPO||143.16%|
Recent News & Updates
|3373||TW Medical Equipment||TW Market|
Return vs Industry: 3373 underperformed the TW Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: 3373 underperformed the TW Market which returned -17.6% over the past year.
|3373 Average Weekly Movement||8.2%|
|Medical Equipment Industry Average Movement||5.5%|
|Market Average Movement||5.0%|
|10% most volatile stocks in TW Market||8.2%|
|10% least volatile stocks in TW Market||2.4%|
Stable Share Price: 3373 is more volatile than 90% of TW stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 3373's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
Radiant Innovation Inc. designs and develops infrared technology products. It offers ear and forehead thermometers, and other body temperature measurement products; and infrared precision thermometers, carbon dioxide detectors, infrared precision thermal imaging cameras, and other instruments. The company was founded in 1989 and is based in Hsinchu City, Taiwan.
Radiant Innovation Fundamentals Summary
|3373 fundamental statistics|
Is 3373 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|3373 income statement (TTM)|
|Cost of Revenue||NT$463.40m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.56|
|Net Profit Margin||3.92%|
How did 3373 perform over the long term?See historical performance and comparison
5.5%Current Dividend Yield
Is 3373 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3373?
Other financial metrics that can be useful for relative valuation.
|What is 3373's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 3373's PE Ratio compare to its peers?
|3373 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
1813 Polylite Taiwan
6543 Perfect Medical Industry
4155 OK Biotech
3373 Radiant Innovation
Price-To-Earnings vs Peers: 3373 is good value based on its Price-To-Earnings Ratio (48.5x) compared to the peer average (48.5x).
Price to Earnings Ratio vs Industry
How does 3373's PE Ratio compare vs other companies in the TW Medical Equipment Industry?
Price-To-Earnings vs Industry: 3373 is expensive based on its Price-To-Earnings Ratio (48.5x) compared to the TW Medical Equipment industry average (20.5x)
Price to Earnings Ratio vs Fair Ratio
What is 3373's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||48.5x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 3373's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 3373 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 3373 (NT$27.2) is trading below our estimate of fair value (NT$33.67)
Significantly Below Fair Value: 3373 is trading below fair value, but not by a significant amount.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Radiant Innovation forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Radiant Innovation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine Radiant Innovation's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
How has Radiant Innovation performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 3373 has a high level of non-cash earnings.
Growing Profit Margin: 3373's current net profit margins (3.9%) are lower than last year (17.6%).
Past Earnings Growth Analysis
Earnings Trend: 3373's earnings have grown significantly by 42.1% per year over the past 5 years.
Accelerating Growth: 3373's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 3373 had negative earnings growth (-93.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (19%).
Return on Equity
High ROE: 3373's Return on Equity (2.4%) is considered low.
Discover strong past performing companies
How is Radiant Innovation's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 3373's short term assets (NT$956.8M) exceed its short term liabilities (NT$176.0M).
Long Term Liabilities: 3373's short term assets (NT$956.8M) exceed its long term liabilities (NT$6.0M).
Debt to Equity History and Analysis
Debt Level: 3373 is debt free.
Reducing Debt: 3373 has not had any debt for past 5 years.
Debt Coverage: 3373 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 3373 has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Radiant Innovation current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 3373's dividend (5.51%) is higher than the bottom 25% of dividend payers in the TW market (2.46%).
High Dividend: 3373's dividend (5.51%) is low compared to the top 25% of dividend payers in the TW market (6.73%).
Stability and Growth of Payments
Stable Dividend: 3373's dividend payments have been volatile in the past 10 years.
Growing Dividend: 3373's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (267.3%), 3373's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 3373 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Radiant Innovation has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Radiant Innovation Inc.'s employee growth, exchange listings and data sources
- Name: Radiant Innovation Inc.
- Ticker: 3373
- Exchange: TPEX
- Founded: 1989
- Industry: Health Care Supplies
- Sector: Healthcare
- Implied Market Cap: NT$1.177b
- Shares outstanding: 43.29m
- Website: https://www.radiantek.com.tw
- Radiant Innovation Inc.
- No. 3, Industrial East 9th Road
- 1st Floor
- Hsinchu City
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|3373||TPEX (Taipei Exchange)||Yes||Common Stock||TW||TWD||Oct 2004|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/24 00:00|
|End of Day Share Price||2022/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.